Skip to main content

Table 3 Multivariate analyses of factors by cox regression model associated with recurrence-free survival (RFS) in test and validation cohort (*, P < 0.05; **, P < 0.01)

From: Evaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome

 

Test cohort

 

Validation cohort

 

Variable

RFS hazard ratio (95% Cl)

Pvalue

RFS hazard ratio (95% Cl)

Pvalue

Tumor size (≤10, > 10 cm)

1.525 (0.465-5.001)

0.486

2.084 (0.901-4.821)

0.086

Mitosis count (≤10, > 10/50 HPF)

3.388 (1.193-9.636)

0.022*

4.117 (1.845-9.185)

0.001**

Serosal invasion (Yes, No)

10.220 (2.862-36.493)

<0.001**

2.960 (1.237-7.079)

0.015*